2008•BoneRequires access

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients

Itsuro Endo, Seiji Fukumoto, Keiichi Ozono, Noriyuki Namba, Hiroyuki Tanaka, Daisuke Inoue, Masanori Minagawa, Toshitsugu Sugimoto, Mika Yamauchi, Toshimi Michigami, Toshio Matsumoto

Open publisher page 209 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 209 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Hypophosphatemia, Hypophosphatemic Rickets, Fibroblast growth factor 23, Osteomalacia, Medicine, Internal medicine, Rickets, Endocrinology

Back to paper search Browse research topics Original source

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients — Research Paper | ScholarLens